[-] Show simple item record

dc.contributor.authorMeurer, Linda N.eng
dc.contributor.authorJamieson, Barbaraeng
dc.date.issued2005eng
dc.description.abstractThe international normalized ratio (INR) should be measured monthly once therapeutic levels are achieved and are stable for at least 8 weeks, although treatment should be individualized and an increased frequency may be required by some patients (strength of recommendation [SOR]: C, consensus statements). For highly compliant patients with stable levels and a clear understanding of factors that influence anticoagulation (changes in health, diet, medications), routine monitoring may be extended to 6 weeks (SOR: B, single randomized controlled trial [RCT]) or longer (SOR: C, case series). Patient-managed warfarin therapy, using biweekly self-measurements, results in more time in therapeutic range than routine physicianmanaged care (SOR: A, RCTs).eng
dc.identifier.urihttp://hdl.handle.net/10355/3373eng
dc.languageEnglisheng
dc.publisherFamily Physicians Inquiries Networkeng
dc.relation.ispartofcollectionClinical Inquiries, 2005 (MU)eng
dc.relation.ispartofcommunityUniversity of Missouri--Columbia. School of Medicine. Department of Family and Community Medicine. Family Physicians Inquiries Networkeng
dc.relation.ispartofseriesJournal of family practice, 54, no. 02 (February 2005): 171+.eng
dc.rightsOpenAccess.eng
dc.rights.licenseThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.eng
dc.subjectinternational normalized ratio (INR)eng
dc.subjectcomplicationseng
dc.subjectanticoagulationeng
dc.subject.lcshWarfarineng
dc.subject.lcshAnticoagulantseng
dc.titleWhat is the interval for monitoring warfarin therapy once therapeutic levels are achieved?eng
dc.typeArticleeng


Files in this item

[PDF]

This item appears in the following Collection(s)

[-] Show simple item record